Filing Details

Accession Number:
0001579618-15-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-16 21:30:43
Reporting Period:
2015-03-12
Filing Date:
2015-03-16
Accepted Time:
2015-03-16 21:30:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Ani Pharmaceuticals Inc ANIP Pharmaceutical Preparations (2834) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579618 Tracy Marshbanks 1 South Wacker Drive
Suite 3900
Chicago IL 60606
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-03-12 143,516 $63.00 375,829 No 4 S Indirect See Footnote 1
Common Stock Disposition 2015-03-12 5,978 $63.00 15,656 No 4 S Indirect See Footnote 2
Common Stock Disposition 2015-03-12 58,265 $63.00 152,579 No 4 S Indirect See Footnote 3
Common Stock Disposition 2015-03-12 2,241 $63.00 5,870 No 4 S Indirect See Footnote 4
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote 1
No 4 S Indirect See Footnote 2
No 4 S Indirect See Footnote 3
No 4 S Indirect See Footnote 4
Footnotes
  1. 1: Held by: FA Private Equity Fund IV, L.P., of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
  2. 2: Held by: FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
  3. 3: Held by: The Productivity Fund IV Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
  4. 4: Held by: The Productivity Fund IV Advisors Fund Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).